Wen Y. Chen

Person

Clemson, SC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of prolactin receptor antagonists in combination with an agent...
- Patent number 8,754,031
- Issue date Jun 17, 2014
- Oncolix, Inc.
- Wen Yuan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human prolactin antagonist-angiogenesis inhibitor fusion proteins
- Patent number 8,304,381
- Issue date Nov 6, 2012
- Oncolix, Inc.
- Wen Y. Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multimeric ligands with enhanced stability
- Patent number 7,632,809
- Issue date Dec 15, 2009
- Oncolix, Inc.
- Wen Yuan Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF receptor antagonists
- Patent number 7,582,726
- Issue date Sep 1, 2009
- GHC Research Development Corporation
- Wen Yuan Chen
- G01 - MEASURING TESTING
Information Patent Grant
Human prolactin antagonist-angiogenesis inhibitor fusion proteins
- Patent number 7,339,027
- Issue date Mar 4, 2008
- GHC Research Development Corporation
- Wen Y. Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bi-functional cancer treatment agents
- Patent number 7,201,905
- Issue date Apr 10, 2007
- Greenville Hospital System
- Wen Y. Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of anti-prolactin agents to treat proliferative conditions
- Patent number 7,115,556
- Issue date Oct 3, 2006
- Greenville Hospital System
- Wen Y. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Human prolactin antagonist-angiogenesis inhibitor fusion proteins
- Publication number 20090088375
- Publication date Apr 2, 2009
- Greenville Hospital System
- Wen Y. Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of anti-prolactin agents to treat proliferative conditions
- Publication number 20070060520
- Publication date Mar 15, 2007
- Greenville Hospital System
- Wen Y. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of prolactin receptor antagonists in combination with an agent...
- Publication number 20050271626
- Publication date Dec 8, 2005
- GREENVILLE HOSPITAL
- Wen Yuan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF receptor antagonists
- Publication number 20050196396
- Publication date Sep 8, 2005
- Greenville Hospital System
- Wen Yuan Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human prolactin antagonist-angiogensis inhibitor fusion proteins
- Publication number 20040127407
- Publication date Jul 1, 2004
- Greenville Hospital System
- Wen Y. Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Multimeric ligands with enhanced stability
- Publication number 20040033948
- Publication date Feb 19, 2004
- Greenville Hospital System
- Wen Yuan Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of anti-prolactin agents to treat proliferative conditions
- Publication number 20030022833
- Publication date Jan 30, 2003
- GREENVILLE HOSPITAL
- Wen Y. Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bi-functional cancer treatment agents
- Publication number 20020068043
- Publication date Jun 6, 2002
- Wen Y. Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Wen Y. Chen

Person

Patents Grantslast 30 patents

Use of prolactin receptor antagonists in combination with an agent...

Human prolactin antagonist-angiogenesis inhibitor fusion proteins

Multimeric ligands with enhanced stability

VEGF receptor antagonists

Human prolactin antagonist-angiogenesis inhibitor fusion proteins

Bi-functional cancer treatment agents

Use of anti-prolactin agents to treat proliferative conditions

Patents Applicationslast 30 patents

Human prolactin antagonist-angiogenesis inhibitor fusion proteins

Use of anti-prolactin agents to treat proliferative conditions

Use of prolactin receptor antagonists in combination with an agent...

VEGF receptor antagonists

Human prolactin antagonist-angiogensis inhibitor fusion proteins

Multimeric ligands with enhanced stability

Use of anti-prolactin agents to treat proliferative conditions

Bi-functional cancer treatment agents